Full Member, McGill Centre for Translational Research in Cancer
Senior Investigator, Lady Davis Institute for Medical Research
Associate Professor, Department of Oncology, McGill University
Dr. Azoulay’s research program is in cancer pharmacoepidemiology. This program aims to provide much needed information on the long-term effects of commonly-prescribed drugs on the incidence of cancer, as well as to assess the safety of cancer treatments in the real-world setting. Over the years, Dr. Azoulay developed a strong interest on the potential effects of anti-diabetic drugs on the development of cancer. With respect to the safety of cancer treatments, he has been particularly interested in the pleiotropic effects of androgen deprivation therapy, a common treatment used in advanced prostate cancer.